Study to Evaluate DNL747 in Subjects With Alzheimer's Disease
Clinical trial NCT03757325 · COMPLETED
Trial details
- NCT number
- NCT03757325
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-13
- Primary completion
- 2019-12-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.